7888 logo

Libo Pharma Corp. Stock Price

TPEX:7888 Community·NT$3.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

7888 Share Price Performance

NT$0
-47.15 (-100.00%)
NT$0
-47.15 (-100.00%)
Price NT$0

7888 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and overvalued.

1 Risk
0 Rewards

Libo Pharma Corp. Key Details

NT$0

Revenue

NT$0

Cost of Revenue

NT$0

Gross Profit

NT$296.3m

Other Expenses

-NT$296.3m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-3.94
0%
0%
0%
View Full Analysis

About 7888

Founded
2017
Employees
20
CEO
n/a
WebsiteView website
libopharma.com

Libo Pharma Corp., a clinical-stage biopharmaceutical company, engage in novel therapeutics development in the field of oncology and hematology. The company offers LIB-101, an interleukin-12 (IL-12) cytokine immunotherapy for innate immunity, adaptive immunity, and hematopoiesis. Libo Pharma Corp. was founded in 2017 and is based in Taipei, Taiwan.

Recent 7888 News & Updates

Recent updates

No updates